MaxCyte CFO Set to Transition in 2026, Initiates Successor Search

Wednesday, Nov 12, 2025 4:09 pm ET1min read

MaxCyte announces CFO Douglas Swirsky's planned transition in H1 2026. Swirsky will remain CFO until a successor is appointed, and the company has initiated a search process. Following the transition, Swirsky will continue in an advisory capacity. The transition is not expected to impact operations, results, or strategic priorities.

MaxCyte CFO Set to Transition in 2026, Initiates Successor Search

Comments



Add a public comment...
No comments

No comments yet